Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kumar Prabhash

Showing results (201-210 of 469) with videos related to

Pageof 47
Sort By:
Therapeutic Advances in Medical Oncology|September 19, 2022
Real-world global data on targeting epidermal growth factor receptor mutations in stage III non-small-cell lung cancer: the results of the KINDLE studyAbdul Rahman Jazieh, Huseyin Cem Onal, Daniel Shao-Weng Tan, et al.
Head & Neck|February 26, 2026
Disparity in the Markers of Affordability Across Targeted- and Immune-Therapy Drugs Used in Head and Neck CancersArjun Gurmeet Singh, Labani Kole, Richard Sullivan, et al.
Plos One|April 27, 2013
EGFR mutations in Indian lung cancer patients: clinical correlation and outcome to EGFR targeted therapyVanita Noronha, Kumar Prabhash, Abhishek Thavamani, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|November 8, 2018
Impact of age on elderly patients with oral cancerAkshat Malik, Aseem Mishra, Prashant Chopda, et al.
Advances in Therapy|March 14, 2019
Biomarkers in Non-Small Cell Lung Cancers: Indian Consensus Guidelines for Molecular TestingKumar Prabhash, Suresh H Advani, Ullas Batra, et al.
Discover Oncology|March 8, 2025
Real world experience with MET inhibitors in MET exon 14 skipping mutated non-small cell lung cancer: largest Indian perspectiveUllas Batra, Ajay Kumar Singh, Shrinidhi Nathany, et al.
European Journal of Clinical Pharmacology|June 13, 2020
Safety and CSF distribution of high-dose erlotinib and gefitinib in patients of non-small cell lung cancer (NSCLC) with brain metastasesBharati Shriyan, Deepali Patil, Murari Gurjar, et al.
Journal of Geriatric Oncology|March 14, 2022
G8 and VES-13 as screening tools for geriatric assessment and predictors of survival in older Indian patients with cancerMinit Shah, Vanita Noronha, Anant Ramaswamy, et al.
Journal of Cancer Research and Therapeutics|July 5, 2025
Imaging-based skeletal muscle quality and clinical outcomes in Indian older patients with cancer: A retrospective analysisAbhijith Rajaram Rao, Vanita Noronha, Anant Ramaswamy, et al.
Cancer Medicine|June 22, 2021
ADME gene polymorphisms do not influence the pharmacokinetics of docetaxel: Results from a population pharmacokinetic study in Indian cancer patientsAnand Patil, Bharati Shriyan, Parsshava Mehta, et al.
Pageof 47

Showing results (201-210 of 469) with videos related to

Sort By:
Pageof 47
Therapeutic Advances in Medical Oncology|September 19, 2022
Real-world global data on targeting epidermal growth factor receptor mutations in stage III non-small-cell lung cancer: the results of the KINDLE studyAbdul Rahman Jazieh, Huseyin Cem Onal, Daniel Shao-Weng Tan, et al.
Head & Neck|February 26, 2026
Disparity in the Markers of Affordability Across Targeted- and Immune-Therapy Drugs Used in Head and Neck CancersArjun Gurmeet Singh, Labani Kole, Richard Sullivan, et al.
Plos One|April 27, 2013
EGFR mutations in Indian lung cancer patients: clinical correlation and outcome to EGFR targeted therapyVanita Noronha, Kumar Prabhash, Abhishek Thavamani, et al.
European Archives of Oto-Rhino-Laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery|November 8, 2018
Impact of age on elderly patients with oral cancerAkshat Malik, Aseem Mishra, Prashant Chopda, et al.
Advances in Therapy|March 14, 2019
Biomarkers in Non-Small Cell Lung Cancers: Indian Consensus Guidelines for Molecular TestingKumar Prabhash, Suresh H Advani, Ullas Batra, et al.
Discover Oncology|March 8, 2025
Real world experience with MET inhibitors in MET exon 14 skipping mutated non-small cell lung cancer: largest Indian perspectiveUllas Batra, Ajay Kumar Singh, Shrinidhi Nathany, et al.
European Journal of Clinical Pharmacology|June 13, 2020
Safety and CSF distribution of high-dose erlotinib and gefitinib in patients of non-small cell lung cancer (NSCLC) with brain metastasesBharati Shriyan, Deepali Patil, Murari Gurjar, et al.
Journal of Geriatric Oncology|March 14, 2022
G8 and VES-13 as screening tools for geriatric assessment and predictors of survival in older Indian patients with cancerMinit Shah, Vanita Noronha, Anant Ramaswamy, et al.
Journal of Cancer Research and Therapeutics|July 5, 2025
Imaging-based skeletal muscle quality and clinical outcomes in Indian older patients with cancer: A retrospective analysisAbhijith Rajaram Rao, Vanita Noronha, Anant Ramaswamy, et al.
Cancer Medicine|June 22, 2021
ADME gene polymorphisms do not influence the pharmacokinetics of docetaxel: Results from a population pharmacokinetic study in Indian cancer patientsAnand Patil, Bharati Shriyan, Parsshava Mehta, et al.
Pageof 47